*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. Also noteworthy is a judgment handed down by the Paris Court of Appeal on March 26, 2015, on an appeal against the decision of the French Competition Authority sanctioning a practice of ousting the generic of the drug princeps Subutex®, in which two procedural questions were debated: the first concerned the prescription period, the second the reasonable time limit. Assessment of the scope of interrupting acts of prescription First of all, this decision of 26 March 2015 is a new illustration of the broad scope that case law gives to acts interrupting the five-year limitation period referred to in Article L. 462-7 of the Commercial Code. More specifically,
CASE COMMENTS: PROCEDURES - INTERRUPTION OF THE TIME-LIMIT – ARTICLE L. 462-7 C. COM. – REASONABLE PERIOD
Time-limit for action : The Paris Court of Appeals considers that acts interrupting the legal time-limit for the action against an abusive practice also interrupt the action against a related anticompetitive agreement (Reckitt Bensicker)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.